ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma.

Blood Advances
Steven I ParkStephen M Ansell

Abstract

Approximately 90% of limited-stage Hodgkin lymphoma (HL) patients are projected to be cured with standard therapy, but many do not live their expected life span because of late treatment-related complications. New treatment paradigms are needed to reduce the use of radiation therapy (RT) as well as conventional chemotherapy drugs while improving upon current standard-of-care survival outcomes. In this phase 2 multicenter study, patients with non-bulky limited-stage HL received doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by brentuximab vedotin (BV) consolidation. Forty-one patients were enrolled, and patient characteristics included median age of 29 years (range, 19 to 67 years), 58% were female, 45% had unfavorable disease, and 98% had stage II disease. Based on positron emission tomography (PET)-based risk stratification, patients received 2 to 6 cycles of ABVD followed by 6 cycles of BV. After ABVD followed by BV, 95% of evaluable patients (37 out of 39; 95% confidence interval [CI], 83%-99%) achieved PET-negative status. In the intent-to-treat patient population, the estimated 3-year progression-free survival (PFS) rate was 92%, and the overall survival (OS) rate was 97%, with a median follow-up of 4...Continue Reading

References

Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J SwerdlowD C Linch
Oct 29, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R K ThomasV Diehl
Nov 23, 2006·Blood·Berthe M P AlemanFlora E van Leeuwen
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Sep 8, 2010·The New England Journal of Medicine·Andreas EngertVolker Diehl
Mar 12, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P M BarbaroD S Ziegler
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea K NgLois B Travis
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony J SwerdlowDavid C Linch
Jun 25, 2013·International Journal of Radiation Oncology, Biology, Physics·Lena SpechtUNKNOWN ILROG
Apr 18, 2014·Blood·Anna M van EggermondFlora E van Leeuwen
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sally F BarringtonBruce D Cheson
Apr 23, 2015·The New England Journal of Medicine·John RadfordSally Barrington
Dec 22, 2015·The Lancet. Haematology·Maja V MaraldoUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group
Dec 25, 2015·The New England Journal of Medicine·Michael SchaapveldFlora E van Leeuwen
Jun 9, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Greg HapgoodKerry J Savage
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc P E AndréJohn Raemaekers
May 10, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Richard T HoppeHema Sundar
Dec 12, 2017·The New England Journal of Medicine·Joseph M ConnorsUNKNOWN ECHELON-1 Study Group
Apr 11, 2018·American Journal of Hematology·Stephen M Ansell
May 1, 2018·British Journal of Haematology·Susan K ParsonsAndrew M Evens
Sep 10, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael FuchsAndreas Engert

❮ Previous
Next ❯

Citations

Feb 20, 2021·Leukemia & Lymphoma·Sanjal Desai, Stephen M Ansell
Mar 24, 2021·Current Treatment Options in Oncology·Xavier Andrade-Gonzalez, Stephen M Ansell
Apr 24, 2021·Blood·Narendranath Epperla, Alex F Herrera

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
George P CanellosAnn S LaCasce
Therapeutic Advances in Hematology
Sarah Tomassetti, Alex F Herrera
Journal of the Formosan Medical Association = Taiwan Yi Zhi
Feng-Ming TienChien-Ting Lin
International Journal of Radiation Oncology, Biology, Physics
Jordan A TorokChris R Kelsey
© 2022 Meta ULC. All rights reserved